Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-20-019793
Filing Date
2020-06-16
Accepted
2020-06-16 18:42:58
Documents
2
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1352
2 POWER OF ATTORNEY (PUBLIC): POARODRIGUEZ061520 doc1.txt EX-24 3052
  Complete submission text file 0001127602-20-019793.txt   5713
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 601 HAWAII ST. EL SEGUNDO CA 90245
Business Address
Rodriguez Javier (Reporting) CIK: 0001415548 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19731 | Film No.: 20967636